11/20
07:05 am
ktta
Pasithea Therapeutics Announces Positive Safety Review Committee (SRC) Recommendation from its ongoing Phase 1 Clinical Trial of PAS-004 in Advanced Cancer [Yahoo! Finance]
High
Report
Pasithea Therapeutics Announces Positive Safety Review Committee (SRC) Recommendation from its ongoing Phase 1 Clinical Trial of PAS-004 in Advanced Cancer [Yahoo! Finance]
11/20
07:02 am
ktta
Pasithea Therapeutics Announces Positive Safety Review Committee (SRC) Recommendation from its ongoing Phase 1 Clinical Trial of PAS-004 in Advanced Cancer
Low
Report
Pasithea Therapeutics Announces Positive Safety Review Committee (SRC) Recommendation from its ongoing Phase 1 Clinical Trial of PAS-004 in Advanced Cancer
10/7
04:54 pm
ktta
Pasithea Therapeutics files to sell 3.74M shares of common stock for holders [Seeking Alpha]
Medium
Report
Pasithea Therapeutics files to sell 3.74M shares of common stock for holders [Seeking Alpha]
9/26
06:44 pm
ktta
Pasithea Therapeutics Announces $5 Million Private Placement Priced At-The-Market Under Nasdaq Rules
Medium
Report
Pasithea Therapeutics Announces $5 Million Private Placement Priced At-The-Market Under Nasdaq Rules
9/26
07:08 am
ktta
Pasithea Therapeutics Announces Positive Initial Safety, Tolerability, Pharmacokinetic (PK), and Preliminary Efficacy Data from its Phase 1 Clinical Trial of PAS-004 in Advanced Cancer [Yahoo! Finance]
High
Report
Pasithea Therapeutics Announces Positive Initial Safety, Tolerability, Pharmacokinetic (PK), and Preliminary Efficacy Data from its Phase 1 Clinical Trial of PAS-004 in Advanced Cancer [Yahoo! Finance]
9/26
07:02 am
ktta
Pasithea Therapeutics Announces Positive Initial Safety, Tolerability, Pharmacokinetic (PK), and Preliminary Efficacy Data from its Phase 1 Clinical Trial of PAS-004 in Advanced Cancer
High
Report
Pasithea Therapeutics Announces Positive Initial Safety, Tolerability, Pharmacokinetic (PK), and Preliminary Efficacy Data from its Phase 1 Clinical Trial of PAS-004 in Advanced Cancer
9/9
08:19 am
ktta
Pasithea Therapeutics Announces Successful Completion of PAS-004 Chronic Toxicity Studies [Yahoo! Finance]
Neutral
Report
Pasithea Therapeutics Announces Successful Completion of PAS-004 Chronic Toxicity Studies [Yahoo! Finance]
9/9
08:01 am
ktta
Pasithea Therapeutics Announces Successful Completion of PAS-004 Chronic Toxicity Studies
Low
Report
Pasithea Therapeutics Announces Successful Completion of PAS-004 Chronic Toxicity Studies
9/3
08:19 am
ktta
Pasithea Therapeutics Announces Appointment of Dr. Rebecca Brown to its Scientific Advisory Board [Yahoo! Finance]
Medium
Report
Pasithea Therapeutics Announces Appointment of Dr. Rebecca Brown to its Scientific Advisory Board [Yahoo! Finance]
9/3
08:02 am
ktta
Pasithea Therapeutics Announces Appointment of Dr. Rebecca Brown to its Scientific Advisory Board
Medium
Report
Pasithea Therapeutics Announces Appointment of Dr. Rebecca Brown to its Scientific Advisory Board
8/28
09:17 am
ktta
Pasithea Therapeutics to Present at the H.C. Wainwright 26th Annual Global Investment Conference [Yahoo! Finance]
Low
Report
Pasithea Therapeutics to Present at the H.C. Wainwright 26th Annual Global Investment Conference [Yahoo! Finance]
8/28
09:11 am
ktta
Pasithea Therapeutics to Present at the H.C. Wainwright 26th Annual Global Investment Conference
Low
Report
Pasithea Therapeutics to Present at the H.C. Wainwright 26th Annual Global Investment Conference